Live Breaking News & Updates on Summit Annual Meeting

Stay updated with breaking news from Summit annual meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocular Therapeutix™ To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting

BEDFORD, Mass., June 05, 2023 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and. | June 5, 2023 ....

Park City , United States , Arshadm Khanani , Jeffrey Heier , Peterk Kaiser , Reenie Mccarthy , Alexander Hardy , Chris Brinzey , Joel Naor , Mohamed Genead , Rabia Gurses Ozden , Donald Notman , Antony Mattessich , Victor Perlroth , Exchange Commission , Globenewswire Inc , Ocular Therapeutix Inc , Sierra Eye Associates , Clinical Research , Ophthalmology Research , Vitreoretinal Service , Retina Research , Cleveland Clinic Lerner College Of Medicine , Summit Annual Meeting , Clinical Trials , Gurses Ozden ,